NCT00348556View on ClinicalTrials.gov

Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Cardiorenal Syndrome

Interventions

DRUG

Nesiritide

Nesiritide 0.005 ug/kg/min IV for 6 hours, then to 0.01 ug/kg/min for 6 hours then to 0.02ug/kg/min for 6 hours then to 0.03 ug/kg/min for the last 6 hours.

Trial Locations (1)

55905

Mayo Clinic, Rochester